These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 9005781)

  • 21. [Pharmacokinetic interaction of fluoroquinolones and other drugs].
    Iakovlev VP
    Antibiot Khimioter; 1998; 43(7):36-44. PubMed ID: 9727166
    [No Abstract]   [Full Text] [Related]  

  • 22. Clinical effects and bronchoalveolar transfer of levofloxacin in patients with community-acquired pneumonia.
    Lin Y; Su W; Xu Z; Bai Y
    Chin Med J (Engl); 2001 Feb; 114(2):212-3. PubMed ID: 11780213
    [No Abstract]   [Full Text] [Related]  

  • 23. The effect of food or milk on the absorption kinetics of ofloxacin.
    Dudley MN; Marchbanks CR; Flor SC; Beals B
    Eur J Clin Pharmacol; 1991; 41(6):569-71. PubMed ID: 1815968
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Structure-tissue distribution relationship based on physiological pharmacokinetics for NY-198, a new antimicrobial agent, and the related pyridonecarboxylic acids.
    Okezaki E; Terasaki T; Nakamura M; Nagata O; Kato H; Tsuji A
    Drug Metab Dispos; 1988; 16(6):865-74. PubMed ID: 2907467
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Determination of ofloxacin in human fallopian tube, uterus and serum by high performance liquid chromatography].
    Zhu GD; Wei J; Liang WW; Xie MQ
    Yao Xue Xue Bao; 2002 Feb; 37(2):134-7. PubMed ID: 12579960
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Effect of antiinflammatory agents on the accumulation of ofloxacin in human polymorphonuclear leukocytes].
    Orero A; Cantón E; Bermejo MV; Velert MM; Cabrera E; Pemán J; Gobernado M
    Rev Esp Quimioter; 1999 Jun; 12(2):144-8. PubMed ID: 10562676
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacokinetic studies in rats with ofloxacin and MF-934, a new fluorinated quinolone.
    Mattina R; Bellotti M; Raimondi A; Sander K
    Chemioterapia; 1987 Jun; 6(2 Suppl):302-3. PubMed ID: 3334569
    [No Abstract]   [Full Text] [Related]  

  • 28. Determinant of the distribution volume at steady state for novel quinolone pazufloxacin in rats.
    Hayakawa H; Takagi K; Takano YF; Kawamura Y; Tsuji A
    J Pharm Pharmacol; 2002 Sep; 54(9):1229-36. PubMed ID: 12356277
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Modification of ofloxacin pharmacokinetics induced by prolonged mechanical ventilation].
    Martin C; Lambert D; Saux P; Meugnier H; Bruguerolle B; Freney J; Fleurette J; Gouin F
    Pathol Biol (Paris); 1990 Jun; 38(5 ( Pt 2)):508-12. PubMed ID: 2385447
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacokinetics, tissue residue and plasma protein binding of ofloxacin in goats.
    Baruah H; Roy DC; Roy RK; Khonikor HN
    J Vet Sci; 2004 Jun; 5(2):97-101. PubMed ID: 15192335
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Distribution and binding kinetics of ciprofloxacin and ofloxacin in the hindlimb of the rat.
    Sanchez-Navarro A; Casquero-Dorado AC; Weiss M
    Pharm Res; 1999 Apr; 16(4):587-91. PubMed ID: 10227717
    [No Abstract]   [Full Text] [Related]  

  • 32. [Comparative pharmacokinetics of lomefloxacin and other fluoroquinolones].
    Iakovlev VP
    Antibiot Khimioter; 1998; 43(10):46-52. PubMed ID: 9825111
    [No Abstract]   [Full Text] [Related]  

  • 33. Comparative assessment of ocular tissue distribution of drug-related radioactivity after chronic oral administration of 14C-levofloxacin and 14C-chloroquine in pigmented rats.
    Tanaka M; Takashina H; Tsutsumi S
    J Pharm Pharmacol; 2004 Aug; 56(8):977-83. PubMed ID: 15285841
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of ofloxacin penetration into the skin after a single oral dose assessed by cutaneous microdialysis.
    Bielecka-Grzela S; Klimowicz A
    Pol J Pharmacol; 2003; 55(4):613-8. PubMed ID: 14581720
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Absorption, distribution and excretion of 14C-levofloxacin after single oral administration in albino and pigmented rats: binding characteristics of levofloxacin-related radioactivity to melanin in vivo.
    Tanaka M; Ono C; Yamada M
    J Pharm Pharmacol; 2004 Apr; 56(4):463-9. PubMed ID: 15099441
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Aqueous and vitreous penetration of topically applied ciprofloxacin and ofloxacin.
    Taustine LR
    J Cataract Refract Surg; 2004 Jan; 30(1):6. PubMed ID: 14967251
    [No Abstract]   [Full Text] [Related]  

  • 37. Pharmacokinetic considerations in quinolone therapy.
    Nightingale CH
    Pharmacotherapy; 1993; 13(2 Pt 2):34S-38S. PubMed ID: 8474936
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacokinetic study of ofloxacin enantiomers in Pagrosomus major by chiral HPLC.
    Nie J; Wang YG; Gao XF; OuYang XK; Yang LY; Yu D; Wu WJ; Xu HP
    Biomed Chromatogr; 2016 Mar; 30(3):426-31. PubMed ID: 26179954
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Determination of levofloxacin in plasma and cerebrospinal fluid with HPLC and its pharmacokinetics in patients undergoing neurosurgical operations].
    Luo S; Lei J; Zhang R; Cai H; Li R
    Yao Xue Xue Bao; 1998 Dec; 33(12):937-40. PubMed ID: 12016861
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Kinetic mechanism for the intestinal absorption of ofloxacin.
    Prieto JG; Barrio JP; Alvarez AI; Gómez G
    J Pharm Pharmacol; 1988 Mar; 40(3):211-2. PubMed ID: 2899154
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.